POL open access to health products
(Unterschied zwischen Versionen)
(Die Seite wurde neu angelegt: „{{tp|p=32382151|t=2020. Protect against market exclusivity in the fight against COVID-19.|pdf=|usr=007}} {{tp|p=32366506|t=2020. Covid-19: Doctors face shortag…“) |
K |
||
Zeile 1: | Zeile 1: | ||
{{tp|p=32382151|t=2020. Protect against market exclusivity in the fight against COVID-19.|pdf=|usr=007}} | {{tp|p=32382151|t=2020. Protect against market exclusivity in the fight against COVID-19.|pdf=|usr=007}} | ||
{{tp|p=32366506|t=2020. Covid-19: Doctors face shortages of vital drugs, gases, and therapeutics, survey finds.|pdf=|usr=007}} | {{tp|p=32366506|t=2020. Covid-19: Doctors face shortages of vital drugs, gases, and therapeutics, survey finds.|pdf=|usr=007}} | ||
+ | {{tp|p=32433624|t=2020. Coronavirus: everyone wins when patents are pooled.|pdf=|usr=007}} | ||
+ | {{tp|p=32449007|t=2020. In and Beyond COVID-19: US Academic Pharmaceutical Science and Engineering Community Must Engage to Meet Critical National Needs.|pdf=|usr=011}} | ||
+ | {{tp|p=32452010|t=2020. Financing Drug Innovation in the US: Current Framework and Emerging Challenges.|pdf=|usr=015}} | ||
+ | {{tp|p=32467411|t=2020. On Patient Safety: COVID-19 Exposes the Dangerous State of Drug and Device Supply Chains.|pdf=|usr=007}} |
Version vom 5. Dezember 2020, 16:43 Uhr
32382151 2020. Protect against market exclusivity in the fight against COVID-19.
32366506 2020. Covid-19: Doctors face shortages of vital drugs, gases, and therapeutics, survey finds.
32433624 2020. Coronavirus: everyone wins when patents are pooled.
32449007 2020. In and Beyond COVID-19: US Academic Pharmaceutical Science and Engineering Community Must Engage to Meet Critical National Needs.
32452010 2020. Financing Drug Innovation in the US: Current Framework and Emerging Challenges.
32467411 2020. On Patient Safety: COVID-19 Exposes the Dangerous State of Drug and Device Supply Chains.